Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
DTx Leader Sidekick Enters Strategic Collaboration With Lilly to Support Patients With Breast Cancer
International digital therapeutics (DTx) innovator, Sidekick Health (www.sidekickhealth.com), today announces an integrated digital therapeutics solution in conjunction […]
Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy
Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced today the recent exercise of […]
Valneva and Pfizer Enter Into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced […]
Aidoc Raises $110M to Address the Increasing Challenges Facing Health Systems by Using Artificial Intelligence
Aidoc, the leading provider of healthcare AI solutions, announced today a $110 million Series D round investment, […]
DiA Imaging Analysis Partners with Intelerad Medical Systems to Empower Echocardiography Labs with AI
Intelerad Medical Systems™, a global leader in medical image management solutions, and DiA Imaging Analysis, a […]
Former Amazon, Oracle Exec Greg Born Joins Amino Health as Chief Growth Officer
Amino Health, the leading digital healthcare guidance platform, today announced that senior global operations executive Greg […]
Mdgroup Appoints Laquinta Jernigan as Chief Operating Officer
mdgroup, the leading global digital and patient-health servicing company pioneering a patient-first approach to clinical […]
Exothera Announces Industrial Scale AAV Manufacturing Collaboration With LogicBio Therapeutics and Polyplus
Exothera SA today announced a collaboration with LogicBio® Therapeutics and Polyplus-transfection® SA. for the development of […]
Center for Breakthrough Medicines Accelerates Plans to Build the Largest Cell Therapy Manufacturing Operation in the World
The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs announced today the […]
seqWell Appoints Dr Amy Liao to Board of Directors
seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more